Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies Therapy
Research on allergies therapy reported by scientists at West Virginia University
April 10th, 2007
Researchers detail in "Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma," new data in allergies. According to a study from the United States, "It has been previously proposed that adenosine plays an important role in the pathogenesis of asthma. The proposed mechanism of action for nucleoside adenosine is to activate A(2B) adenosine receptors (AR) and to indirectly modulate levels of mediators in the lung." "In vivo data supporting the role of A(2B) AR in airway reactivity and inflammation in allergic animal models are lacking. The...
Source: Drug Law Weekly (2007-04-10)
|
